Ipsen reaches licensing deal with Rhythm Pharmaceuticals

03/15/2010 | Reuters

Boston-based Rhythm Pharmaceuticals has acquired worldwide rights from Ipsen to develop and commercialize drugs for diabetes, obesity and digestive diseases. The licensing deal calls for Rhythm to pay the French biotech firm as much as $80 million in milestone fees and royalties on future products.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations